Cutera Reports First Quarter 2018 Financial Results

Medical Device Investing

Cutera (NASDAQ:CUTR) a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ending March 31, 2018. As quoted in the press release: “Our first quarter performance in North America was strong, as system revenue grew 31% over last year. Continued demand for truSculpt 3D and the …

Cutera (NASDAQ:CUTR) a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ending March 31, 2018.

As quoted in the press release:

“Our first quarter performance in North America was strong, as system revenue grew 31% over last year. Continued demand for truSculpt 3D and the launch of our Juliet and Secret RF systems drove our results,” stated President and CEO, James Reinstein.  “The overall performance in international was weighed down by a temporary administrative regulatory issue in Japan.  Now resolved, this issue impacted our ability to import units into Japan for part of Q1 and over-shadowed very strong growth in Europe, the Middle East, and Australia.  Net net, we still expect to achieve our full year revenue goal.  While growth continues to drive our performance, we also continue to experience collateral ‘growing pains’ that reflect our focus on appropriately scaling our organization for the long term.  Since I joined Cutera in early 2017, improving the Company’s infrastructure has been a top priority in order for the Company to sustain these impressive growth rates. We made significant progress in a short period of time and I expect continued improvements to be reflected in our financial results going forward. The overwhelming positive customer feedback we heard at the recent ASLMS conference supports what we are striving to accomplish at Cutera.  Ultimately, we expect our efforts in scaling the Company to generate strong long-term shareholder value.”

Click here to read the full press release.

The Conversation (0)
×